81results about How to "Convenient medical treatment" patented technology

Methods for determining genotypes and haplotypes of genes are described. Also described are single nucleotide polymorphisms and haplotypes in the ApoE gene and methods of using that information.

Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.

Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity. The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.

Clinical content analytics engines and associated processes are described. An engine receives a clinical decision support document, accesses corresponding reference content, identifies and extracts medical intervention content from the clinical decision support document, segments extracted medical intervention content into a first plurality of segments including at least a first segment comprising a first set of text, determines if the first segment corresponds to at least a first item included in the reference content, the first item comprising a second set of text comprising terminology different than that found in the first set of text, and in response to determining that the first segment corresponds to the first item included in the reference content, causing a report to include an indication that the first segment corresponds to the first item included in the reference content.

In an embodiment, a method to enhance a non-surgical medical treatment, the method including applying a composition having an antifibrinolytic agent to an area of skin for non-surgical medical treatment, where the applying is at least one of before, during, and after the non-surgical medical treatment, beginning the non-surgical medical treatment to the area of skin, and continuing the non-surgical medical treatment until the non-surgical medical treatment is completed. In some embodiments, the antifibrinolytic agent is tranexamic acid in an amount of about 20% (w/v). In some embodiments, the method further includes minimizing, by the antifibrinolytic agent, bruising caused by the non-surgical medical treatment. In an additional embodiment, the present disclosure relates to a composition to enhance a non-surgical medical treatment, the composition having an antifibrinolytic agent. In a further embodiment, the present disclosure relates to a kit having a carrier and an antifibrinolytic agent.

An improved medical treatment and medicine is provided to quickly and safely resolve herpes and other microbial infections. The inexpensive user-friendly medicine can be applied and maintained on the infected region until the physical symptoms of the disease disappears and the patient is comfortable and has a normal appearance. The attractive medicine comprises an antimicrobial concentrate comprising microbe inhibitors, phytochemicals or isolates. Desirably, the effective medicine comprises a surfactant and an aqueous carrier or solvent. In the preferred form, the medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution.

A fabric material including a plurality of strands of a warp yarn positioned in a warp direction, a plurality of strands of a first filling yarn positioned in a filling direction, each being impregnated by silver ions, and a plurality of strands of a second filling yarn positioned in the filling direction, each being impregnated by copper ions. The strands of said warp yarn are woven with those of the first and second filling yarns to form a face side and a back side, and the strands of the first and second filling yarns are woven alternately relative to one another with the strands of said warp yarn in said filling direction. The fabric material may be a satin, plain or twill pattern, and can be used as a bed sheet having a low coefficient of friction, wickability, absorbency, and “cool to the touch” properties.

The invention discloses a novel medical diagnosis and treatment device for obstetrical and gynecological diseases. The device comprises a base, wherein an air cylinder is arranged on the upper surface of the base, the expansion end of the air cylinder is provided with a main body plate, a sliding chute is formed in the surface of one side of the main body plate, an expansion plate is in sliding connection in the sliding chute, a control panel is arranged on the upper surface of the base, the input end of the control panel is electrically connected with the output end of an external power supply, the surface of the other side of the main body plate is connected with a connecting plate through a hinged support, and the lateral surface of the connecting plate is in rotating connection with a leg placing plate through a rotating shaft. The novel medical diagnosis and treatment device for obstetrical and gynecological diseases has simple structure, convenient operation, lower cost and easy popularization, and greatly improves the working efficiency; the height of the device can be adjusted by the air cylinder according to requirements in use, thereby improving the universality; and the expansion plate can be retracted into the sliding chute of the main body plate when not used, and the leg placing plate can be folded through the hinged support when not used, thereby reducing the occupied area and improving the space utilization ratio.

An apparatus and method are provided for providing medical data based on a handover of a medical sensor. The apparatus includes a medical data client that requests and receives the medical data from the medical sensor; a security module that manages access to the medical data; a data management unit that stores the received medical data; and an event handler that receives an abnormal condition notification from the medical sensor and sends a command to release access to the medical data, based on the abnormal condition notification.

This invention relates to a method for diagnosing whether or not a subject suffers from depression in a simple manner with high accuracy using the peripheral whole blood sample of the subject. Specifically, the present invention relates to a method for diagnosing depression comprising the steps of: measuring expression levels of 18 genes selected from the group consisting of FASLG; CX3CR1, TBX21, ID2, SLAMF7, PRSS23, YWHAQ, TARDBP, ADRB2, PPP1R8, MMAA, SQLE, PDHA1, HAVCR2, RACGAP1, AHNAK, EDG8, and DUSP5, in peripheral blood isolated from a subject; and determining whether or not the subject suffers from depression based on the expression levels of the 18 genes.

The invention relates to a disinfecting therapeutic device which comprises a drug pasting layer and a breathable waterproof pasting film, a peeling wheel, a bar-shaped sterile applying paste, a sterile applying paste wheel, a push rod, a piston, a needle tube type hollow liquid storage cavity, plant pigment dyeing cotton, a disinfectant nozzle, release paper, a rocker handle and a release paper winding wheel, wherein a disinfecting medium comprises the disinfectant nozzle, a disinfecting brush and a disinfecting cotton block. The disinfecting therapeutic device can reduce the risk in postoperative infection and can ensure the success rate of operation; when a local part cannot be smeared, the disinfectant nozzle can be assembled and used for spraying disinfectant to a tiny or serious festered wound; the pollution caused by external environment or improper contact is avoided; the disinfecting quality is ensured. The disinfecting therapeutic device has the advantages of simple structure, low manufacturing cost, good use effect, popularization and application in industry and capability of realizing the full effective preoperative disinfection and simple drug topical application binding pretreatment.

The invention relates to graphene smart clothes. The smart clothes are characterized in comprising a temperature monitoring part, a graphene heating sheet made by taking polyester, polypropylene or polyamide polymer fiber cloth as a substrate, and a data collection and processing part, wherein the graphene heating sheet comprises a graphene film which is arranged on the flexible substrate and is generated on the basis of a small mechanically-stripped graphene film in a solid carbon source sputtering way, and a nano-scale coating circuit obtained by taking the graphene film as a substrate in a sputtering or imprinting way; the intelligent clothes control the graphene heating sheet to emit heat based on monitoring data of the temperature monitoring part and control data of the data collection and processing part. The smart clothes have the characteristics of convenience in use and realization of real-time detection and control on human body temperature; moreover, far infrared radiation emitted by the graphene heating sheet is harmless to a human body, and good medical care effects of improving the body microcirculation system and promoting the metabolism are achieved.

The invention discloses a method for preventing or treating conjunctivitis and herpes zoster palpebral dermatitis, bear gall powder used by the method, and a preparation method of the bear gall powder. The bear gall powder can be used for regulating blood lipid, lowering total cholesterol, preventing cardiovascular and cerebrovascular diseases and preventing atherosclerosis. Materials are subjected to ice crystallization during the preparation of the bear gall powder, and then freeze drying is performed to obtain the freeze-dried bear gall powder which can be called ice-crystalized bear gall powder. The Senbao ice-crystalized bear gall powder does not contain any auxiliary materials and chemical additives, can effectively regulate the blood lipid and lower the total cholesterol, can be effectively used for preventing cardiovascular and cerebrovascular diseases and atherosclerosis and preventing and treating solid tumor and blood system tumor, and can be particularly effectively used for preventing or treating the conjunctivitis and herpes zoster palpebral dermatitis.

In a method for providing medical assistance in the event of an in-flight medical emergency during a passenger flight, training is provided to medical practitioners in the handling of in-flight medical emergencies; an identification scheme is established that allows medical practitioners who completed the training to be identified; it is determined, by means of the identification scheme, if a medical practitioner who completed the training is present as a passenger of the passenger flight; and the medical practitioner is asked to provide the medical assistance. The invention improves the medical treatment of emergency patients during a flight and avoids legal uncertainties, which presently arise when a passenger who steps forward in an in-flight medical emergency is allowed to treat a patient.

The invention discloses a method for preventing or treating solid tumors and blood system tumors and bear gall powder used in the same. The bear gall powder can be used for adjusting blood fat, reducing total cholesterol, preventing cardiovascular and cerebrovascular diseases, preventing atherosclerosis and treating or preventing the solid tumors and the blood system tumors. The invention discloses a preparation method of the bear gall powder and the bear gall powder obtained through the method. In a bear gall powder preparation process, a material is subjected to ice crystallization and thenfreeze drying, and the obtained freeze dried bear gall powder can be called ice crystal-state bear gall powder or ice crystal bear gall powder; especially, the bear gall powder which can be called senbao bear gall powder does not contain any auxiliaries or chemical additives; more especially, the invention finds that the ice crystal-state bear gall powder can not only more effectively adjust the blood fat and reduce the total cholesterol, but also more effectively be used for preventing the cardiovascular and cerebrovascular diseases, preventing atherosclerosis and the like, and more especially, the ice crystal-state bear gall powder can effectively be used for preventing and treating the solid tumors and blood system tumors.

The invention discloses an air cleaning device capable of conveniently treating deposited dust, which solves the problem that deposited dust is difficult to treat in the current air cleaner. The air cleaning device capable of conveniently treating deposited dust, comprises a machine body, an air inlet and an air outlet, and an ultraviolet tube, a fan, a fan motor, an active carbon filter layer and an anion generator are arranged in the machine body. The air cleaning device is characterized in that a drawer capable of storing deposited dust is arranged in the machine body, thus solving the long-time problem that deposited dust is difficult to treat.

A computerized client-server based comprehensive computerized method of health care administration that utilizes concepts from ICD codes, CPT codes, and superbills to both handle medical cost accounting, organize the activity of healthcare professionals, and improve communication of important aspects of the patient's medical record. The system is based on a wireless network client-server model in which healthcare professionals in all participating institutions and departments wirelessly communicate with a server using their respective handheld computerized devices such as smartphones and tablet computers. The software methods capture patient referral information, patient admission data, diagnosis, treatment, help organize the sign-off and rounding list process. The system also generates superbills, produces discharge reports, and ensures communication between all participating medical professionals.

A method for determining if a patient has a traumatic brain injury includes obtaining a body specimen from the patient, determining the concentration of marinobufagenin in the body specimen, comparing the concentration of marinobufagenin to the concentration in such body specimens in normal persons, and if the marinobufagenin concentration is substantially above the concentration of a normal person, concluding traumatic brain injury exists. In a preferred embodiment, a substantial elevation is deemed to be an increase of about 30 percent above the marinobufagenin concentration of a normal person. The body specimen may be blood or urine. If a substantial elevation is deemed to exist, the magnitude from the departure from the concentration of a normal person may be employed in determining the timing and nature of treatment provided to the patient. The method may be repeated at predetermined intervals to monitor changes in the marinobufagenin with time. Corresponding apparatus is provided.